Clinical Trial Update: Motor-Sparing Femoral Nerve Block Dose [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on motor-sparing femoral nerve block dose for knee conditions is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Injuries
• Osteoarthritis of the Knee

Snippet

Sponsor: University of Chile | Conditions: Osteoarthritis, Knee, Knee Injuries | Phase 4 | Status: TERMINATED